Sun Pharma shareholders approve amalgamation scheme
Shares of the company were trading at Rs 857.50 per scrip in the afternoon trade on BSE, up 3.05% from its previous close
)
An employee speaks on phone as he walks out of research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai
Sun Pharmaceutical today said court convened meeting of its shareholders has approved the scheme of amalgamation of Sun Pharma Global Inc with itself.
The scheme of amalgamation of Sun Pharma Global Inc with Sun Pharmaceutical Industries has been "approved by the equity shareholders with requisite majority," Sun Pharma said in a filing to the BSE.
A total of 99.99 per cent votes were polled in favour of amalgamation scheme, it added.
Sun Pharma has been present in the US since 1996, working with the country's healthcare system with a focus on generics, branded generics and over-the-counter (OTC) products.
Shares of Sun Pharmaceutical Industries were trading at Rs 857.50 per scrip in the afternoon trade on BSE, up 3.05 per cent from its previous close.
ALSO READ: Sun Pharma Q4 net down 44% at Rs 888 cr
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 05 2015 | 2:56 PM IST